121 related articles for article (PubMed ID: 19404917)
21. Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer.
Zhai K; Yang Y; Gao ZG; Ding J
Oncotarget; 2017 Jul; 8(27):44490-44497. PubMed ID: 28548958
[TBL] [Abstract][Full Text] [Related]
22. Association of interferon-gamma +874A polymorphism with the risk of developing cervical cancer in north-Indian population.
Gangwar R; Pandey S; Mittal RD
BJOG; 2009 Nov; 116(12):1671-7. PubMed ID: 19681846
[TBL] [Abstract][Full Text] [Related]
23. Relationship between single nucleotide polymorphisms in -174G/C and -634C/G promoter region of interleukin-6 and prostate cancer.
Bao S; Yang W; Zhou S; Ye Z
J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):693-6. PubMed ID: 19107369
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6 -174G/C polymorphism in breast cancer and uterine leiomyoma patients: a population-based case control study.
Litovkin KV; Domenyuk VP; Bubnov VV; Zaporozhan VN
Exp Oncol; 2007 Dec; 29(4):295-8. PubMed ID: 18199986
[TBL] [Abstract][Full Text] [Related]
25. IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians.
Zidi S; Gazouani E; Stayoussef M; Mezlini A; Ahmed SK; Yacoubi-Loueslati B; Almawi WY
Cytokine; 2015 Dec; 76(2):343-347. PubMed ID: 26076679
[TBL] [Abstract][Full Text] [Related]
26. Interaction of tobacco chewing and smoking habit with interleukin 6 promoter polymorphism in oral precancerous lesions and oral cancer.
Shahi Y; Mukherjee S; Samadi FM
Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):4011-4019. PubMed ID: 33501560
[TBL] [Abstract][Full Text] [Related]
27. Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma.
Singhal P; Kumar A; Bharadwaj S; Hussain S; Bharadwaj M
Tumour Biol; 2015 Apr; 36(4):2287-98. PubMed ID: 25412954
[TBL] [Abstract][Full Text] [Related]
28. Association Between the IL-6 rs1800795 Polymorphism and the Risk of Cervical Cancer: A Meta-Analysis of 1210 Cases and 1525 Controls.
Liu H; Lyu D; Zhang Y; Sheng L; Tang N
Technol Cancer Res Treat; 2017 Oct; 16(5):662-667. PubMed ID: 27777338
[TBL] [Abstract][Full Text] [Related]
29. Promoter polymorphisms in IL-6 gene influence pro-inflammatory cytokines for the risk of osteoarthritis.
Singh M; Mastana S; Singh S; Juneja PK; Kaur T; Singh P
Cytokine; 2020 Mar; 127():154985. PubMed ID: 31951965
[TBL] [Abstract][Full Text] [Related]
30. Association between IL-6-174G/C polymorphism and risk of multiple sclerosis: a meta-analysis.
Hu S; Chen Y; Sun XD; Li FJ; Shu QF; Liu XL; Jiang SF
Genet Test Mol Biomarkers; 2014 Feb; 18(2):127-30. PubMed ID: 24328460
[TBL] [Abstract][Full Text] [Related]
31. Impact of interleukin-6 -174 G>C gene promoter polymorphism on neuroblastoma.
Totaro F; Cimmino F; Pignataro P; Acierno G; De Mariano M; Longo L; Tonini GP; Iolascon A; Capasso M
PLoS One; 2013; 8(10):e76810. PubMed ID: 24204677
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer.
Du GH; Wang JK; Richards JR; Wang JJ
Int Immunopharmacol; 2019 Jan; 66():154-161. PubMed ID: 30453149
[TBL] [Abstract][Full Text] [Related]
33. CCR5-Delta32 polymorphism and susceptibility to cervical cancer: association with early stage of cervical cancer.
Singh H; Sachan R; Jain M; Mittal B
Oncol Res; 2008; 17(2):87-91. PubMed ID: 18543610
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphisms of interleukin 6 and interleukin 10 in Egyptian patients with systemic lupus eythematosus.
Talaat RM; Alrefaey SA; Bassyouni IH; Ashour ME; Raouf AA
Lupus; 2016 Mar; 25(3):255-64. PubMed ID: 26568585
[TBL] [Abstract][Full Text] [Related]
35. Genetic variations in interleukin-6 polymorphism and the association with susceptibility and overall survival of osteosarcoma.
Qi Y; Zhao C; Li H; Zhang B; Tada K; Abe H; Tada M
Tumour Biol; 2016 Jul; 37(7):9807-11. PubMed ID: 26810186
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.
Zidi S; Sghaier I; Gazouani E; Mezlini A; Yacoubi-Loueslati B
Pathol Oncol Res; 2016 Apr; 22(2):323-30. PubMed ID: 26548749
[TBL] [Abstract][Full Text] [Related]
37. Association between -174G>C polymorphism in the IL-6 promoter region and the risk of obesity: A meta-analysis.
Hu M; Yu Z; Luo D; Zhang H; Li J; Liang F; Chen R
Medicine (Baltimore); 2018 Aug; 97(33):e11773. PubMed ID: 30113463
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism of interleukin-6 -174 G/C (rs1800795) & the corresponding interleukin-6 level as a prognostic marker of cervical cancer.
Wagh P; Kulkarni P; Kerkar S; Tongaonkar H; Chaudhari H; Warke H; Deodhar K; Rekhi B; Mania-Pramanik J
Indian J Med Res; 2021 Aug; 154(2):391-398. PubMed ID: 34854425
[TBL] [Abstract][Full Text] [Related]
39. Relationships between Common and Novel Interleukin-6 Gene Polymorphisms and Risk of Cervical Cancer: a Case-Control Study.
Zidi S; Stayoussef M; Alsaleh BL; Gazouani E; Mezlini A; Ebrahim BH; Yacoubi-Loueslati B; Almawi WY
Pathol Oncol Res; 2017 Apr; 23(2):385-392. PubMed ID: 27722983
[TBL] [Abstract][Full Text] [Related]
40. Association of IL-6 -174 G>C Polymorphism with Susceptibility to Colorectal Cancer and Gastric Cancer: a Systematic Review and Meta-Analysis.
Jafari-Nedooshan J; Dastgheib SA; Kargar S; Zare M; Raee-Ezzabadi A; Heiranizadeh N; Sadeghizadeh-Yazdi J; Neamatzadeh H
Acta Medica (Hradec Kralove); 2019; 62(4):137-146. PubMed ID: 32036845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
